Ventyx Biosciences Inc [NASDAQ: VTYX] traded at a low on Wednesday, posting a -10.71 loss after which it closed the day’ session at $2.25.
The results of the trading session contributed to over 5401071 shares changing hands. Over the past one week, the price volatility of Ventyx Biosciences Inc stands at 10.44% while the volatility over the past one month is 9.13%.
The market cap for VTYX stock reached $159.10 million, with 70.67 million shares outstanding and 52.89 million shares in the current float. Compared to the average trading volume of 1.52M shares, VTYX reached a trading volume of 5401071 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Ventyx Biosciences Inc [VTYX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VTYX shares is $11.14 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VTYX stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for Ventyx Biosciences Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on March 12, 2024. The new note on the price target was released on March 12, 2024, representing the official price target for Ventyx Biosciences Inc stock. Previously, the target price had yet another drop from $77 to $8, while Wells Fargo kept a Equal Weight rating on VTYX stock.
The Average True Range (ATR) for Ventyx Biosciences Inc is set at 0.21 The Price to Book ratio for the last quarter was 0.57, with the Price to Cash per share for the same quarter was set at 3.89.
How has VTYX stock performed recently?
Ventyx Biosciences Inc [VTYX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.74. With this latest performance, VTYX shares dropped by -27.88% in over the last four-week period, additionally sinking by -7.79% over the last 6 months – not to mention a drop of -13.46% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VTYX stock in for the last two-week period is set at 47.04, with the RSI for the last a single of trading hit 45.21, and the three-weeks RSI is set at 48.14 for Ventyx Biosciences Inc [VTYX]. The present Moving Average for the last 50 days of trading for this stock 2.29, while it was recorded at 2.36 for the last single week of trading, and 2.95 for the last 200 days.
Ventyx Biosciences Inc [VTYX]: Deeper insight into the fundamentals
Ventyx Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 23.52 and a Current Ratio set at 23.52.
Insider trade positions for Ventyx Biosciences Inc [VTYX]
There are presently around $84.63%, or 88.61%% of VTYX stock, in the hands of institutional investors. The top three institutional holders of VTYX stocks are: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with ownership of 5.83 million shares, which is approximately 9.4284%. CITADEL ADVISORS LLC, holding 5.76 million shares of the stock with an approximate value of $$13.3 million in VTYX stocks shares; and CITADEL ADVISORS LLC, currently with $$12.12 million in VTYX stock with ownership which is approximately 8.4872%.
